|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
|
MA49156A
(fr)
|
2014-12-23 |
2020-03-25 |
Immatics Biotechnologies Gmbh |
Nouveaux peptides et combinaison de peptides à utiliser dans l'immunothérapie contre le carcinome hépatocellulaire (hcc) et d'autres cancers
|
|
US9422547B1
(en)
|
2015-06-09 |
2016-08-23 |
Gigagen, Inc. |
Recombinant fusion proteins and libraries from immune cell repertoires
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
DE102016123893A1
(de)
|
2016-12-08 |
2018-06-14 |
Immatics Biotechnologies Gmbh |
T-Zellrezeptoren mit verbesserter Bindung
|
|
US10676516B2
(en)
|
2017-05-24 |
2020-06-09 |
Pandion Therapeutics, Inc. |
Targeted immunotolerance
|
|
US10946068B2
(en)
|
2017-12-06 |
2021-03-16 |
Pandion Operations, Inc. |
IL-2 muteins and uses thereof
|
|
US10174092B1
(en)
|
2017-12-06 |
2019-01-08 |
Pandion Therapeutics, Inc. |
IL-2 muteins
|
|
EP3731876A4
(en)
*
|
2017-12-28 |
2022-04-06 |
Gritstone bio, Inc. |
ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS
|
|
WO2019204683A1
(en)
*
|
2018-04-19 |
2019-10-24 |
Board Of Regents, The University Of Texas System |
T cell receptors with mage-b2 specificity and uses thereof
|
|
WO2020037302A1
(en)
*
|
2018-08-17 |
2020-02-20 |
Gritstone Oncology, Inc. |
Antigen-binding proteins targeting shared antigens
|
|
CN111138522B
(zh)
*
|
2018-11-06 |
2023-01-24 |
香雪生命科学技术（广东）有限公司 |
衍生自afp的肿瘤抗原短肽
|
|
CN111138521B
(zh)
*
|
2018-11-06 |
2022-10-28 |
香雪生命科学技术（广东）有限公司 |
源自于afp抗原的短肽
|
|
CN114026116A
(zh)
*
|
2019-02-20 |
2022-02-08 |
弗雷德哈钦森癌症研究中心 |
Ras新抗原特异性结合蛋白及其用途
|
|
WO2020191365A1
(en)
*
|
2019-03-21 |
2020-09-24 |
Gigamune, Inc. |
Engineered cells expressing anti-viral t cell receptors and methods of use thereof
|
|
EP3714941A1
(en)
*
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
US20200318068A1
(en)
*
|
2019-04-04 |
2020-10-08 |
Immatics US, Inc. |
Use of retinoic acid in t-cell manufacturing
|
|
WO2020206238A2
(en)
|
2019-04-05 |
2020-10-08 |
Rootpath Genomics, Inc. |
Compositions and methods for t-cell receptor gene assembly
|
|
EP3962939A4
(en)
*
|
2019-05-03 |
2023-05-17 |
Gigamune, Inc. |
MODIFIED CELLS EXPRESSING ANTITUMOR T-LYMPHOCYTE RECEPTORS AND METHODS OF USING THEM
|
|
CA3139011A1
(en)
|
2019-05-08 |
2020-11-12 |
Medigene Immunotherapies Gmbh |
Engineered t cells
|
|
BR112021023345A2
(pt)
|
2019-05-20 |
2022-02-01 |
Pandion Operations Inc |
Imunotolerância com alvo em madcam
|
|
EP3760217A1
(en)
*
|
2019-07-01 |
2021-01-06 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Cd5 specific t cell receptor cell or gene therapy
|
|
KR20220052910A
(ko)
*
|
2019-07-09 |
2022-04-28 |
메디진 이뮤노테라피스 게엠바하 |
Ｍａｇｅａ10 특이적 ｔ 세포 수용체 및 이의 용도
|
|
KR20240137107A
(ko)
|
2019-07-16 |
2024-09-19 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 백신, 및 이의 제조 및 사용 방법
|
|
CN112300261B
(zh)
*
|
2019-07-23 |
2023-03-17 |
香雪生命科学技术（广东）有限公司 |
一种衍生自afp的肿瘤抗原短肽
|
|
BR112022003163A2
(pt)
*
|
2019-08-19 |
2022-05-17 |
Pandion Operations Inc |
Imunotolerância alvejada com um agonista de pd-1
|
|
WO2021048381A1
(en)
*
|
2019-09-13 |
2021-03-18 |
Evaxion Biotech Aps |
Method for identifying stable mhc binding peptides using mass spectrometry
|
|
US20220372092A1
(en)
*
|
2019-10-18 |
2022-11-24 |
Board Of Regents, The University Of Texas System |
Hla-restricted vcx/y peptides and t cell receptors and use thereof
|
|
WO2021092094A1
(en)
*
|
2019-11-04 |
2021-05-14 |
Gritstone Oncology, Inc. |
Antigen-binding proteins targeting shared neoantigens
|
|
KR20220098379A
(ko)
*
|
2019-11-15 |
2022-07-12 |
그릿스톤 바이오, 인코포레이티드 |
공유 네오항원을 표적으로 하는 항원-결합 단백질
|
|
CN112898399A
(zh)
*
|
2019-12-03 |
2021-06-04 |
香雪生命科学技术（广东）有限公司 |
源自于afp抗原的短肽
|
|
CN115960206A
(zh)
*
|
2019-12-13 |
2023-04-14 |
南京大户生物科技有限公司 |
原发性肝癌相关抗原的胸腺依赖性淋巴细胞抗原表位肽及其应用
|
|
CN113072636B
(zh)
*
|
2020-01-06 |
2024-05-28 |
香雪生命科学技术（广东）有限公司 |
一种识别afp的t细胞受体及其编码序列
|
|
EP4107187A4
(en)
|
2020-02-21 |
2024-07-03 |
Pandion Operations, Inc. |
TISSUE-TARGETED IMMUNOTOLERANCE WITH A CD39 EFFECTOR
|
|
CN113321725B
(zh)
*
|
2020-02-28 |
2024-06-11 |
香雪生命科学技术（广东）有限公司 |
一种识别afp的t细胞受体
|
|
CN113321727B
(zh)
*
|
2020-02-28 |
2024-04-09 |
香雪生命科学技术（广东）有限公司 |
一种识别afp抗原短肽的t细胞受体及其编码序列
|
|
BR112022017924A2
(pt)
*
|
2020-03-10 |
2022-12-20 |
Massachusetts Inst Technology |
Composições e métodos para imunoterapia de câncer npm1c-positivo
|
|
JP2023517063A
(ja)
*
|
2020-03-10 |
2023-04-21 |
マサチューセッツ インスティテュート オブ テクノロジー |
操作されたメモリー様ｎｋ細胞を作製するための方法およびその組成物
|
|
CN113493505A
(zh)
*
|
2020-03-20 |
2021-10-12 |
香雪生命科学技术（广东）有限公司 |
识别afp抗原的高亲和力tcr
|
|
CN113621070A
(zh)
|
2020-05-06 |
2021-11-09 |
华夏英泰（北京）生物技术有限公司 |
一种t细胞抗原受体、其多聚体复合物及其制备方法和应用
|
|
AU2021276264A1
(en)
*
|
2020-05-18 |
2022-12-22 |
Board Of Regents, The University Of Texas System |
Engineered T cell receptors and methods of use
|
|
CA3183756A1
(en)
|
2020-05-19 |
2021-11-25 |
Amgen Inc. |
Mageb2 binding constructs
|
|
WO2021252517A1
(en)
*
|
2020-06-09 |
2021-12-16 |
Board Of Regents, The University Of Texas System |
Engineered t cell receptors and methods of use
|
|
WO2022010274A1
(ko)
|
2020-07-08 |
2022-01-13 |
주식회사 엘지에너지솔루션 |
배터리 팩, 및 이를 포함하는 자동차
|
|
US20240059797A1
(en)
*
|
2020-07-29 |
2024-02-22 |
Gritstone Bio, Inc. |
Engineered multi-specific antibodies and related methods of use and manufacture
|
|
TWI900647B
(zh)
*
|
2020-09-04 |
2025-10-11 |
美國衛生與公眾服務部 |
識別p53中r273c或y220c突變的t細胞受體
|
|
BR112023005296A2
(pt)
*
|
2020-09-24 |
2023-04-25 |
Medigene Immunotherapies Gmbh |
Receptores de células t específicos de mage-a3 e uso dos mesmos
|
|
MX2023003372A
(es)
*
|
2020-09-24 |
2023-05-04 |
Medigene Immunotherapies Gmbh |
Nuevos receptores prame y usos de los mismos.
|
|
AU2021366741A1
(en)
*
|
2020-10-23 |
2023-05-11 |
Rootpath Genomics, Inc. |
Compositions and methods for t-cell receptor identification
|
|
JP2023548556A
(ja)
*
|
2020-11-05 |
2023-11-17 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
Ｅｇｆｒ抗原を標的とする操作されたｔ細胞受容体および使用方法
|
|
WO2022155503A1
(en)
*
|
2021-01-14 |
2022-07-21 |
Gritstone Bio, Inc. |
Multi-specific antibodies and methods of use
|
|
US12053517B2
(en)
|
2021-01-14 |
2024-08-06 |
Gilead Sciences, Inc. |
HIV vaccines and methods of using
|
|
WO2022177961A1
(en)
*
|
2021-02-16 |
2022-08-25 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hla class i–restricted t cell receptors against cd22
|
|
US12435444B2
(en)
|
2021-03-09 |
2025-10-07 |
Cdr-Life Ag |
Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the same
|
|
MX2023010541A
(es)
|
2021-03-09 |
2023-11-24 |
Cdr Life Ag |
Proteinas de union al antigeno del peptido del mhc mage-a4.
|
|
KR20240005714A
(ko)
*
|
2021-03-29 |
2024-01-12 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
Sars-cov-2 항원을 표적화하는 펩티드 및 조작된 t 세포 수용체 및 사용 방법
|
|
WO2022216574A1
(en)
*
|
2021-04-05 |
2022-10-13 |
Janssen Biotech, Inc. |
Calr and jak2 t-cell receptors
|
|
WO2022229966A1
(en)
|
2021-04-29 |
2022-11-03 |
Yeda Research And Development Co. Ltd. |
T cell receptors directed against ras-derived recurrent neoantigens and methods of identifying same
|
|
EP4091627A1
(en)
*
|
2021-05-21 |
2022-11-23 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Tcr constructs specific for magea4-derived epitopes
|
|
CN117545766A
(zh)
*
|
2021-05-25 |
2024-02-09 |
纪念斯隆-凯特琳癌症中心 |
靶向ras突变的t细胞受体及其用途
|
|
KR20240045239A
(ko)
*
|
2021-08-06 |
2024-04-05 |
안야디, 엘엘씨 |
개인 맞춤형 암 면역치료제 제조방법
|
|
WO2023050063A1
(zh)
*
|
2021-09-28 |
2023-04-06 |
溧阳瑅赛生物医药有限公司 |
一种识别hla-a*02:01/e629-38的tcr及其应用
|
|
EP4422651A4
(en)
*
|
2021-10-25 |
2025-12-17 |
Univ Texas |
PEPTIDES AND MANIPULATED T-CELL RECEPTORS FOR TARGETTING THE MAGE-A4 ANTIGEN AND METHOD FOR USE
|
|
JP2024540197A
(ja)
*
|
2021-10-29 |
2024-10-31 |
ホウ，ヤフェイ |
Ｐ５３におけるｒ１７５ｈ変異を認識するｔ細胞受容体およびその用途
|
|
EP4472742A1
(en)
*
|
2022-02-03 |
2024-12-11 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
CA3244259A1
(en)
*
|
2022-02-23 |
2023-08-31 |
Aloe Therapeutics Inc |
Compositions and methods for modulating the immune system
|
|
NL2031118B1
(en)
*
|
2022-03-01 |
2023-09-07 |
Academisch Ziekenhuis Leiden |
T cell receptors directed against transcription factor wt1 and uses thereof
|
|
CN116836261A
(zh)
*
|
2022-03-24 |
2023-10-03 |
香雪生命科学技术（广东）有限公司 |
一种识别mage-a4抗原的高亲和力tcr及其序列和应用
|
|
CN117264043B
(zh)
*
|
2022-06-14 |
2024-05-10 |
上海镔铁生物科技有限责任公司 |
靶向kras g12v突变多肽的t细胞受体及其用途
|
|
CA3264474A1
(en)
|
2022-09-14 |
2024-03-21 |
Cdr-Life Ag |
MAGE-A4 DOUBLE T LYMPHOCYTE ENGAGEMENT
|
|
EP4598569A1
(en)
*
|
2022-10-05 |
2025-08-13 |
Tscan Therapeutics, Inc. |
Magea1 immunogenic peptides, binding proteins recognizing magea1 immunogenic peptides, and uses thereof
|
|
CN116158405B
(zh)
*
|
2023-01-30 |
2024-04-26 |
西北农林科技大学 |
一种提高奶山羊后代母羔率的方法
|
|
WO2025064738A1
(en)
*
|
2023-09-22 |
2025-03-27 |
Regeneron Pharmaceuticals, Inc. |
Dntt 250-258 off-target peptides and uses thereof
|
|
AU2024374117A1
(en)
*
|
2023-10-30 |
2026-04-09 |
T-Knife Gmbh |
Antigen-recognizing construct capable of binding to a frame peptide and a t cell receptor
|
|
CN118256604B
(zh)
*
|
2024-04-16 |
2024-11-19 |
华中科技大学 |
一种利用人工抗原呈递细胞进行免疫原性肿瘤新抗原筛选与鉴定方法
|